Current insights on clinical efficacy of roflumilast for treatment of COPD, asthma and ACOS

S Bodkhe, M Nikam, AP Sherje, T Khan… - International …, 2020 - Elsevier
Abstract Phosphodiesterase-4 inhibitors (PDE4) are of great interest for the treatment of
airway inflammatory diseases due to its broad anti-inflammatory effects. Roflumilast is a …
被引用次数：20 相关文章

Current insights on clinical efficacy of roflumilast for treatment of COPD, asthma and ACOS.

S Bodkhe, M Nikam, AP Sherje, T Khan… - International …, 2020 - europepmc.org
Phosphodiesterase-4 inhibitors (PDE4) are of great interest for the treatment of airway
inflammatory diseases due to its broad anti-inflammatory effects. Roflumilast is a selective …

Current insights on clinical efficacy of roflumilast for treatment of COPD, asthma and ACOS

S Bodkhe, M Nikam, AP Sherje… - International …, 2020 - pubmed.ncbi.nlm.nih.gov
Phosphodiesterase-4 inhibitors (PDE4) are of great interest for the treatment of airway
inflammatory diseases due to its broad anti-inflammatory effects. Roflumilast is a selective …